Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Subcutaneous estrogen replacement therapy.

Stephen C Jones1

  • 1Department of Obstetrics and Gynecology, Keesler Medical Center, Keesler Air Force Base, Mississippi 39534, USA. stephen.jones@keesler.af.mil

The Journal of Reproductive Medicine
|April 22, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quantitative Imaging of the Heterogeneity of Brain Potassium Depletion in Experimental Focal Ischemia.

bioRxiv : the preprint server for biology·2026
Same author

Proof-of-concept validation of noninvasive detection of cortical spreading depolarization with high-resolution direct current-electroencephalography with future device recommendations.

Imaging neuroscience (Cambridge, Mass.)·2025
Same author

Proof-of-Concept Validation of Noninvasive Detection of Cortical Spreading Depolarization with High Resolution Direct Current-Electroencephalography with Future Device Recommendations.

medRxiv : the preprint server for health sciences·2024
Same author

Characteristics, surgical treatment, and outcomes of injuries involving the tarsus in greyhounds.

Frontiers in veterinary science·2023
Same author

Effect of screw insertion angle and speed on the incidence of transcortical fracture development in a canine tibial diaphyseal model.

Veterinary surgery : VS·2023
Same author

Does changing the Functional Movement Screen composite score threshold influence injury risk estimation in junior Australian football players?

Journal of sports sciences·2023
Same journal

Elective Procedures in Obstetrics and Gynecology During the COVID-19 Pandemic.

The Journal of reproductive medicine·2022
Same journal

Choriocarcinoma in Situ in a Partial Hydatidiform Mole A: Case Report.

The Journal of reproductive medicine·2018
Same journal

Isolated Recurrent Hematotrachelos After Abdominal Myomectomy A Case Report.

The Journal of reproductive medicine·2018
Same journal

Live Birth from Electively Cryopreserved Oocytes: A Feasible Option for Couples Opposed to Embryo Cryopreservation A Case Report.

The Journal of reproductive medicine·2018
Same journal

Prevalence and Risk Factors of Ejaculation Failure on the Day of Operation Among Chinese Males Undergoing Assisted Reproductive Technique Treatments.

The Journal of reproductive medicine·2018
Same journal

Efficacy and Safety of Perioperative Use of Epinephrine for Laparoscopic Myomectomy in Infertile Women with Symptomatic Solitary Intramural Uterine Fibroids A Randomized Clinical Trial.

The Journal of reproductive medicine·2018
See all related articles

Subcutaneous estradiol pellet therapy effectively manages menopausal symptoms and protects against osteoporosis by restoring physiologic hormone levels. This minor procedure offers long-term benefits, with re-dosing typically needed every six months.

Area of Science:

  • Endocrinology
  • Gynecology
  • Menopause Management

Background:

  • Menopausal hormone therapy aims to alleviate symptoms and prevent bone loss.
  • Subcutaneous estradiol pellets offer a long-acting delivery method for estrogen replacement.

Purpose of the Study:

  • To describe the efficacy and administration of subcutaneous estradiol pellet therapy.
  • To highlight benefits including symptom relief and osteoporosis prevention.

Main Methods:

  • Insertion of estradiol pellets (starting dose 25 mg) into the subcutaneous tissue of the lower abdomen or buttocks.
  • Monitoring of estradiol and follicle-stimulating hormone levels.
  • Concurrent testosterone supplementation if indicated.
  • Progesterone therapy for patients with an intact uterus.

Related Experiment Videos

Main Results:

  • Achieves physiologic estradiol levels and suppresses follicle-stimulating hormone, mimicking premenopausal states.
  • Provides relief from climacteric symptoms and protection against osteoporosis.
  • Redosing is typically required every 6 months based on symptom recurrence and serum levels.

Conclusions:

  • Subcutaneous estradiol pellet therapy is an effective method for hormone replacement in menopausal women.
  • The procedure is well-tolerated and offers significant benefits for symptom management and bone health.
  • Individualized dosing and monitoring ensure optimal patient outcomes.